Why the study?
Does smoking increase the prevalence of common diseases and metabolic abnormalities in community-dwelling Japanese individuals?
Does smoking increase the prevalence of common diseases and metabolic abnormalities in community-dwelling Japanese individuals?
Smoking is significantly associated with various metabolic abnormalities and a higher prevalence of common diseases like dyslipidemia and metabolic syndrome in Japanese men, which may accelerate cardiovascular disease development.
Answers are grounded in this paper and cite their sources.
Smoking-metabolic associations in Japanese men remain observational; hypothesis-generating and should not yet change practice.
Smoking is a significant risk factor for cardiovascular diseases (CVDs). Given that certain common pathologies, including hypertension, dyslipidemia and type 2 diabetes mellitus, are major risk factors for CVDs, the association of smoking with CVDs may be attributable, at least in part, to its effects on common diseases. The aim of the present study was to determine the association of smoking with the prevalence of common diseases and metabolic abnormalities in community‑dwelling Japanese individuals. The study included 5,959 subjects (1,302 current smokers, 1,418 past smokers and 3,239 nonsmokers) recruited to the Inabe Health and Longevity Study, a longitudinal genetic epidemiological study of atherosclerotic, cardiovascular and metabolic diseases. Various metabolic parameters and prevalence of common diseases were compared between smokers and nonsmokers using multivariable regression or logistic regression analysis with adjustments for age. Analysis indicated significantly higher serum concentrations of triglycerides and lower concentrations of high‑density lipoprotein (HDL)‑cholesterol in current smokers compared with nonsmokers in men and women. Serum concentrations of creatinine and systolic blood pressure were significantly lower and estimated glomerular filtration rate was higher in male current smokers. In addition, body weight was higher in female current smokers. In multivariable logistic regression analysis, smoking was significantly associated with the prevalence of dyslipidemia [P=6.3x10‑10; odds ratio (OR), 1.81], hypertriglyceridemia (P=2.3x10‑20; OR, 2.39), hypo‑HDL‑cholesterolemia (P=2.0x10‑9; OR, 2.14), metabolic syndrome (P=0.0003; OR, 1.61) and chronic kidney disease (P=4.4x10‑15; OR, 0.54) in men, but not in women. The results indicated that smoking is significantly associated with various metabolic abnormalities and prevalence of common diseases in Japanese individuals, with certain sex differences, which may lead to accelerated development of CVDs.
No takes yet. Share an insight, caveat, or question.
Ueyama et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: